Peter Lindell — Board member
Roles
19.06.2026 – 07.07.2026
Transactions (including via associated entities)
| Date | Issuer | Nature | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 07.07.2026 | Spago Nanomedical AB (publ) Stockholm | Ownership restructuring | 3,927,154 | — | No cash value 3,927,154 shares | ↗ |
| 07.07.2026 | Spago Nanomedical AB (publ) Stockholm | Ownership restructuring | 59,846,450 | — | No cash value 59,846,450 shares | ↗ |
| 07.07.2026 | Spago Nanomedical AB (publ) Stockholm | Ownership restructuring | 1,867,578 | — | No cash value 1,867,578 shares | ↗ |
| 07.07.2026 | Spago Nanomedical AB (publ) Stockholm | Ownership restructuring | 96,076 | — | No cash value 96,076 shares | ↗ |
| 19.06.2026✎ | Spago Nanomedical AB (publ) Stockholm | New shares (subscription) | 3,927,154 | SEK 0.11 | SEK 431,986.94 | ↗ |
| 19.06.2026✎ | Spago Nanomedical AB (publ) Stockholm | New shares (subscription) | 59,846,450 | SEK 0.11 | SEK 6,583,109.50 | ↗ |
| 19.06.2026✎ | Spago Nanomedical AB (publ) Stockholm | New shares (subscription) | 96,076 | SEK 0.11 | SEK 10,568.36 | ↗ |
| 19.06.2026✎ | Spago Nanomedical AB (publ) Stockholm | New shares (subscription) | 1,867,578 | SEK 0.11 | SEK 205,433.58 | ↗ |